Co-Diagnostics: enters financing agreements with J.J. Astor & Co.

What happened Co-Diagnostics, Inc. filed a Current Report on Form 8-K on Oct 15, 2026 reporting that on Oct 9, 2026 it entered into material definitive agreements with J.J. Astor & Co. The filing reports the creation of a direct financial obligation and reports unregistered sales of equity securities. The filing states, "Except as expressly set forth herein, this Amendment does not amend, update or restate any other information in the Original Form 8-K."

Key details

• Loan Agreement between Co-Diagnostics, Inc. and J.J. Astor & Co., dated Oct 9, 2026.
• Form of Senior Secured Convertible Note, Pledge and Security Agreement, and Subsidiary Guarantee are referenced in the filing (incorporated by reference to the Current Report on Form 8-K filed Oct 13, 2026).
• ATM Waterfall Distribution Agreement and ATM Payment Direction Letter dated Oct 9, 2026; Placement Agency Agreement with Maxim Group LLC dated Oct 9, 2026.
• The report includes the creation of a direct financial obligation (Item 2.03) and unregistered sales of equity securities (Item 3.02).

Why it may matter Item 1.01 reports entry into material definitive agreements related to financing and related security documents. Item 2.03 reports the creation of a direct financial obligation. Item 3.02 reports unregistered sales of equity securities. This filing does not show why the insider traded or why the company acted.